| Financial Year |
March 31 2023 |
| Monetary Funds |
2,091,375,649.91 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
569,394,805.55 |
| Advances to Suppliers |
169,753,519.03 |
| Other Receivables |
61,398,659.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
6,245,731,412.79 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
372,699,528.82 |
| Total Current Assets |
9,537,363,933.53 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
253,418,714.49 |
| Long-term Equity Investment |
1,001,093,250.25 |
| Investment Properties |
183,936,771.20 |
| Fixed Assetes |
3,604,896,250.86 |
| Under-construction Projects |
244,544,969.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
91,102,026.81 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
282,795,515.15 |
| Deferred Income Tax Assets |
111,465,870.59 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
6,230,971,524.04 |
| Total Assets |
15,768,335,457.57 |
| Short-Term Loans |
1,793,306,644.08 |
| Trading Financial liabilities |
-- |
| Notes Payable |
38,975,000.00 |
| Accounts Payable |
628,706,510.71 |
| Accounts Received In Advance |
20,551,235.59 |
| Employee Compensation Payable |
105,501,822.88 |
| Taxes Payable |
80,252,709.22 |
| Interest Payable |
-- |
| Dividend Payable |
15,372,079.06 |
| Other payables |
332,397,670.71 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
842,520,353.88 |
| Other Current Liabilities |
356,422,310.33 |
| Sub-Total of Current Liabilities |
8,793,734,428.28 |
| Long-term Loans |
1,785,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
567,908,895.34 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
31,179,219.65 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,977,754,227.82 |
| Total Liabilities |
11,771,488,656.10 |
| Paid-In Capital(Or Share Stock) |
578,261,934.00 |
| Capital Surplus |
414,966,794.69 |
| Surplus Reserve |
182,864,916.41 |
| LESS:Treasury Stock |
13,925,200.00 |
| Undistributed Profits |
1,687,631,189.03 |
| Minority Stockholder's Interest |
1,129,840,248.81 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,867,006,552.66 |
| Owner's Equity（Stockholder's Equity） |
3,996,846,801.47 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,768,335,457.57 |
